ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,70%(-0,017) 1D
20-ноя., 17:29:34 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 миң
Volume
286,21 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 миң
Volume
286,21 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
54 мүнөт мурун
S&P 500 Session Movers: Fair Isaac Leads Gainers, Coherent Leads Decliners
WHEC.com
·
48 мүнөт мурун
US stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
TradingView
·
1 саат мурун
S&P 500 enters correction territory and these 20 names are fueling the leg lower
investingLive
·
1 саат мурун
NASDAQ composite is now down on the year
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com